[5]
a) Wan, C.; Liu, X.; Wang, J.; Chen, F.; Cheng, D.G. Heterostructuring 2D Co2P nanosheets with 0D CoP via a salt-assisted strategy for boosting hydrogen evolution from ammonia borane hydrolysis.
Nano Res., 2023,
16(5), 6260-6269.
[
http://dx.doi.org/10.1007/s12274-023-5388-5];
b) Panchal, J.; Jain, S.; Jain, P.K.; Kishore, D.; Dwivedi, J. Greener approach toward synthesis of biologically active s‐TRIAZINE (TCT) derivatives: A recent update.
J. Heterocycl. Chem., 2021,
58(11), 2049-2066.
[
http://dx.doi.org/10.1002/jhet.4343];
c) Misra, A.; Dwivedi, J.; Shukla, S.; Kishore, D.; Sharma, S. Bacterial cell leakage potential of newly synthesized quinazoline derivatives of 1,5‐benzodiazepines analogue.
J. Heterocycl. Chem., 2020,
57(4), 1545-1558.
[
http://dx.doi.org/10.1002/jhet.3879];
d) Mishra, S.; Dwivedi, J.; Kumar, A.; Sankararamakrishnan, N. Removal of antimonite (Sb(III)) and antimonate (Sb(V)) using zerovalent iron decorated functionalized carbon nanotubes.
RSC Advances, 2016,
6(98), 95865-95878.
[
http://dx.doi.org/10.1039/C6RA18965B];
e) Rani, M.; Sharma, S.; Chauhan, R.; Sharma, S.; Dwivedi, J. Synthesis, characterization and antibacterial evaluation of some azole derivatives.
Indian J. Pharmaceut. Educ. Res., 2017,
51(4), 650-655.
[
http://dx.doi.org/10.5530/ijper.51.4.96];
f) Shukla, S.; Dwivedi, J.; Yaduvanshi, N.; Jain, S. Medicinal and biological significance of phenoxazine derivatives.
Mini Rev. Med. Chem., 2021,
21(12), 1541-1555.
[
http://dx.doi.org/10.2174/1389557520666201214102151] [PMID:
33319658]
[17]
a) Gosalia, U.A.; Srivastava, M.; Yaduvanshi, N.; Jaiswal, S.; Jain, S.; Kishore, D.; Dwivedi, J.; Sharma, S. One-pot mediated synthesis of pyrimidine and quinazoline annulated derivatives of nitrogen containing five membered rings through their nitrile derivatives as antibacterial agents. Bull. Chem. Soc. Ethiop., 2023, 37(5), 1193-1208.;
b) Siddiqui, N.; Husain, A. Pharmacological and pharmaceutical profile of valsartan: A review. J. Appl. Pharm. Sci., 2011, 12-19.;
c) Jiang, X. Continuous-flow oxidation of amines based on nitrogen-rich heterocycles: A facile and sustainable approach for promising nitro derivatives. Org. Process Res. Dev., 2022, 26(10), 2823-2829.;
d) Shen, T. In vivo and in vitro evaluation of in situ gel formulation of pemirolast potassium in allergic conjunctivitis. Drug Des. Devel. Ther., 2021, 15, 2099-2107.;
e) Li, S. Green synthesis of gold nanoparticles for immune response regulation: Mechanisms, applications, and perspectives. J. Biomed. Mater. Res. A, 2022, 110(2), 424-442.;
f) Roberti, R. Pharmacology of cenobamate: Mechanism of action, pharmacokinetics, drug-drug interactions and tolerability. CNS Drugs, 2021, 35(6), 609-618.;
g) Seyed Hashtroudi, M. Ru-catalyzed one-pot synthesis of heterocyclic backbones. Catalysts, 2023, 131, 87.;
h) Puskarich, M.A. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine, 2021, 37.;
i) Soni, A. A decade of synthesis of N-heterocyclic derivatives via magnetically retrievable Fe3O4@ SiO2@ Cu (II) nanocatalysts: A review (2013-present). Synth. Commun., 2023, 1-37.;
j) Ghobadi, E. Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development. Eur. J. Med. Chem., 2022, 231, 14161.;
k) Wang, T. Functionalized tetrazole energetics: A route to enhanced performance. Z. Anorg. Allg. Chem., 2021, 647(4), 157-191.
[19]
a) Kaushik, N.; Kumar, N.; Kumar, A.; Singh, U.K. Tetrazoles: Synthesis and biological activity.
Immunol. Endocr. Metab. Agents Med. Chem., 2018,
18(1), 3-21.
[
http://dx.doi.org/10.2174/1871522218666180525100850];
b) Xu, Y.; Kong, J.; Hu, P. Computational drug repurposing for Alzheimer’s disease using risk genes from GWAS and single-cell RNA sequencing studies.
Front. Pharmacol., 2021,
12, 617537.
[
http://dx.doi.org/10.3389/fphar.2021.617537] [PMID:
34276354];
c) Devi, M.; Jaiswal, S.; Yaduvanshi, N.; Kaur, N.; Kishore, D.; Dwivedi, J.; Sharma, S. Design, synthesis, antibacterial evaluation and docking studies of triazole and tetrazole linked 1,4‐benzodiazepine nucleus via click approach.
ChemistrySelect, 2023,
8(6), e202204710.
[
http://dx.doi.org/10.1002/slct.202204710];
d) Sain, S.; Jaiswal, S.; Jain, S.; Misra, N.; Srivastava, A.; Jendra, R.; Kishore, D.; Dwivedi, J.; Wabaidur, S.M.; Islam, M.A.; Sharma, S. Synthesis and theoretical studies of biologically active thieno nucleus incorporated Tri and tetracyclic nitrogen containing heterocyclics scaffolds via suzuki cross‐coupling reaction.
Chem. Biodivers., 2022,
19(12), e202200540.
[
http://dx.doi.org/10.1002/cbdv.202200540] [PMID:
36310125];
e) Devi, M.; Jaiswal, S.; Dwivedi, J.; Kaur, N. Synthetic aspects of condensed pyrimidine derivatives.
Curr. Org. Chem., 2021,
25(21), 2625-2649.
[
http://dx.doi.org/10.2174/1385272825666210706123734];
f) Devi, M.; Jaiswal, S.; Yaduvanshi, N.; Jain, S.; Jain, S.; Verma, K.; Verma, R.; Kishore, D.; Dwivedi, J.; Sharma, S. Design, synthesis, molecular docking, and antibacterial study of aminomethyl triazolo substituted analogues of benzimidazolo [1,4]-benzodiazepine.
J. Mol. Struct., 2023,
1286, 135571.
[
http://dx.doi.org/10.1016/j.molstruc.2023.135571];
g) Jaiswal, S.; Devi, M.; Sharma, N.; Rathi, K.; Dwivedi, J.; Sharma, S. Emerging approaches for synthesis of 1,2,3-triazole derivatives. A review.
Org. Prep. Proced. Int., 2022,
54(5), 387-422.
[
http://dx.doi.org/10.1080/00304948.2022.2069456]
[27]
Pokatilov, F.A.; Akamova, H.V.; Kizhnyaev, V.N. Synthesis and properties of tetrazole-containing polyelectrolytes based on chitosan, starch, and arabinogalactan. e-Polymers,, 2022, 221, 203-213.
[72]
Collection, M.A.; Nikoorazm, M.; Tahmasbi, B.; Ghorbani-Choghamarani, A. Homoselective Synthesis of tetrazoles and chemoselective oxidation of sulfides using Ni (II)-Schiff base complex stabilized on 3-dimensional mesoporous KIT-6 surface as a recyclable nanocatalyst. Inorg. Chem. Commun., 2023, 111852.
[103]
Vedpathak, S.G.; Momle, R.G.; Kakade, G.K.; Ingle, V.S. An improved and convenient route for the synthesis of 5-methyl-1H-tetrazol-1-yl substituted benzenamines. World J. Pharm. Res., 2016, 5(12), 1049-1057.